Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCambridge Cog Share News (COG)

Share Price Information for Cambridge Cog (COG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 42.00
Bid: 41.00
Ask: 43.00
Change: 0.50 (1.20%)
Spread: 2.00 (4.878%)
Open: 41.50
High: 42.00
Low: 41.50
Prev. Close: 41.50
COG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: AFC gets Extreme E boost; Chamberlin raises cash

Wed, 02nd Feb 2022 10:32

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

----------

AIM - WINNERS

----------

Cambridge Cognition Holdings PLC, up 15% at 138.67 pence, 12-month range 68.00p-195.00p. The Cambridge, England-based digital neuroscience company wins a GBP2.1 million deal to provide cognitive assessments, electronic diaries, and third-party hardware to two clinical trials focused on neurodegenerative disease.

----------

AFC Energy PLC, up 11% at 37.87 pence, 12-month range 30.40p-83.00p. All-electric off-road SUV racing series Extreme E will continue using the company's zero-emission fuel cell for its 2022 season. The Surrey, England-based hydrogen power generation technology company's L series hydrogen power generator was used at all five races in the inaugural Extreme E 2021 season.

----------

AIM - LOSERS

----------

Chamberlin PLC, down 29% at 5.17p, 12-month range 5.00p-15.50p. The castings and engineering firm proposes placing and subscription to raise GBP1.8 million at five pence per share, a 31% discount to its closing price on Tuesday. "The additional funds from the placing and subscription are expected to enable the company to execute its strategy and will strengthen the company's balance sheet, giving it more flexibility to manage and achieve its optimum financial position," Chamberlin says. Shares hit this 12 month low on Wednesday.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
19 Dec 2018 08:52

Cambridge Cognition shares tumble as revenues fall short of expectations

(Sharecast News) - Neuroscience technology developer Cambridge Cognition has seen revenues fall short of expectations and losses widen as a result of a switch in accounting practices.

Read more
20 Sep 2018 12:35

Cambridge Cognition Holdings Loss Widens As Revenue Drops

LONDON (Alliance News) - Cambridge Cognition Holdings PLC said Thursday that its loss for the first half of the financial year widened as it recorded a drop in revenue as a result of the new IFRS

Read more
19 Sep 2018 12:45

Cambridge Cognition To Provide NeuroVocalix For Virtual Clinical Tests

LONDON (Alliance News) - Cambridge Cognition Holdings PLC on Wednesday said it signed its first commercial contract with an undisclosed pharmaceutical firm for its recently launched NeuroVocalix a

Read more
19 Sep 2018 10:14

Cambridge Cognition announces first NeuroVocalix commercial partnership

(Sharecast News) - Neuroscience technology company Cambridge Cognition Holdings announced its first commercial partnership for its recently launched 'NeuroVocalix' voice biomarker technology on Wednesday.

Read more
13 Sep 2018 11:14

Cambridge Cognition's NeuroVocalix Set For Clinical Trial Use

LONDON (Alliance News) - Neuroscience technology firm Cambridge Cognition Holdings PLC on Thursday said its NeuroVocalix platform is ready for clinical trials.NeuroVocalix, the company to a

Read more
1 Aug 2018 11:51

Cambridge Cognition Inks US Production Distribution For CANTAB

LONDON (Alliance News) - Cambridge Cognition Holdings PLC said Wednesday that it signed a commercial collaboration with health provider Healthy Amplified to launch its software product to better a

Read more
17 May 2018 16:01

UK Shareholder Meetings Calendar - Next 7 Days

Friday 18 MayPaddy Power BetfairIndependent News & (T)PetrofacJohn Group (re by

Read more
22 Mar 2018 13:03

Cambridge Cognition Shares Fall As It Swings To Annual Loss

LONDON (Alliance News) - Shares fell in Cambridge Cognition Holdings PLC on Thursday as it swung to a loss in 2017 from a maiden profit due to higher costs and lower in the at

Read more
14 Mar 2018 12:47

Oil majors give in to investors with share buyback spree

By Nivedita Bhattacharjee March 14 (Reuters) - After almost three barren years for investors who have poured millions into the U.S. oil sector, producers are finally to

Read more
25 Jan 2017 08:27

Cambridge Cognition gains US regulatory approval for memory test

(ShareCast News) - Neuroscience digital health company Cambridge Cognition has gained regulatory clearance for its memory test to be used as a medical device in the US. Cantab Mobile, which detects clinically-relevant memory impairment in older adults at the point of care, received 510k clearance fo

Read more
13 Oct 2016 10:55

Cambridge Cognition confirms series of new contracts

(ShareCast News) - Neuroscience company Cambridge Cognition Holdings announced a series of new contracts worth more than £0.25m on Thursday, to assess - through CANTAB Connect - the abuse potential of investigational drugs in a new market application for the company. The AIM-traded firm claimed that

Read more
22 Sep 2016 10:23

Cambridge Cognition's sales up after investments in marketing

(ShareCast News) - Cambridge Cognition' half-year revenues grew and losses were more than halved as the neuroscience software and hardware company's invested in marketing and development. For the six months ended 30 June, revenue increased by 11.3% to £3.26, compared to the same period last year. T

Read more
22 Sep 2016 08:51

Cambridge Cognition Loss Narrows On Strong Revenue Growth

Read more
20 Sep 2016 08:07

Cambridge Cognition Inks First Contract For CANTAB Recruit Product

Read more
16 Aug 2016 13:49

Cambridge Cognition announces promising results from technology study

(ShareCast News) - Neuroscience company Cambridge Cognition Holdings announced results on Tuesday from a new technology feasibility study. The AIM-traded firm, which develops and markets near-patient technologies for the assessment of brain health to improve the drug development process, said the re

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.